Accumulation of macrophages in the CSF of schizophrenic patients during acute psychotic episodes

American Journal of Psychiatry

Volumn 156, Issue 11, 1999, Pages 1725-1729

  Nikkilä, Heikki V ^a   Müller, Kiti ^b   Ahokas, Antti ^b   Miettinen, Kati ^b   Rimón, Ranan ^b   Andersson, Leif C ^b  

^a FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; FEMALE; HUMAN; MACROPHAGE; MALE; MICROSCOPY; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA;

ACUTE DISEASE; ADULT; CELL COUNT; CEREBROSPINAL FLUID; FEMALE; HUMANS; LYMPHOCYTES; MACROPHAGES; MALE; MONOCYTES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0344117155     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Kety SS, Wender PH, Jacobsen B, Ingraham LJ, Jansson L, Faber B, Kinney DK: Mental illness in the biological and adoptive relatives of schizophrenic adoptees: replication of the Copenhagen Study in the rest of Denmark. Arch Gen Psychiatry 1994; 51:442-455
2. Cannon TD, Mednick SA, Parnas J, Schulsinger F, Praestholm J, Vestergaard A: Developmental brain abnormalities in the offspring of schizophrenic mothers, II: structural brain characteristics of schizophrenia and schizotypal personality disorder. Arch Gen Psychiatry 1994; 51:955-962
3. Murray RM, Jones P, O'Callaghan E: Genes, viruses and neurodevelopmental schizophrenia. J Psychiatr Res 1992; 26: 225-235
4. Hirata-Hibi M, Hayashi K: The anatomy of the P lymphocyte. Schizophr Res 1993; 8:257-262
5. Muller N, Ackenheil M, Hofschuster E, Mempel W, Eckstein R: Cellular immunity, HLA-class I antigens, and family history of psychiatric disorder in endogenous psychoses. Psychiatry Res 1993; 48:201-217
6. Henneberg AE, Horter S, Ruffert S: Increased prevalence of antibrain antibodies in the sera from schizophrenic patients. Schizophr Res 1994; 14:15-22
7. Nikkilä H, Müller K, Ahokas A, Miettinen K, Andersson LC, Rimón R: Abnormal distributions of T-lymphocyte subsets in the cerebrospinal fluid of patients with acute schizophrenia. Schizophr Res 1995; 14:215-221
8. Seeman P, Guan HC, Van-Tol HH: Dopamine D4 receptors elevated in schizophrenia. Nature 1993; 365:441-445
9. Ricci A, Amenta F: Dopamine D5 receptors in human peripheral blood lymphocytes: a radioligand binding study. J Neuroimmunol 1994; 53:1-7
10. Joyce JN, Shane A, Lexow N, Winokur A, Casanova MF, Kleinman JE: Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics. Neuropsychopharmacology 1993; 8:315-336
11. Laruelle M, Abi-Dargham A, Casanova MF, Toti R, Weinberger DR, Kleinman JE: Selective abnormalities of prefrontal serotonergic receptors in schizophrenia: a postmortem study. Arch Gen Psychiatry 1993; 50:810-818
12. Farde L, Nordstrom AL, Nyberg S, Halldin C, Sedvall G: D1-, D2-, and 5-HT2-receptor occupancy in clozapine-treated patients. J Clin Psychiatry 1994; 55(Sept suppl B):67-69
13. Suddath RL, Casanova MF, Goldberg TE, Daniel DG, Kelsoe JR Jr, Weinberger DR: Temporal lobe pathology in schizophrenia: a quantitative magnetic resonance imaging study. Am J Psychiatry 1989; 146:464-472
14. Suddath RL, Christison GW, Torrey EF, Casanova MF, Weinberger DR: Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia. N Engl J Med 1990; 322:789-794
15. DeLisi LE, Hoff AL, Schwartz JE, Shields GW, Halthore SN, Gupta SM, Henn FA, Anand AK: Brain morphology in first-episode schizophrenic-like psychotic patients: a quantitative magnetic resonance imaging study. Biol Psychiatry 1991; 29: 159-175
16. Zipursky RB, Lim KO, Sullivan EV, Brown BW, Pfefferbaum A: Widespread cerebral gray matter volume deficits in schizophrenia. Arch Gen Psychiatry 1992; 49:195-205
17. Schlaepfer TE, Harris GJ, Tien AY, Peng LW, Lee S, Federman EB, Chase GA, Barta PE, Pearlson GD: Decreased regional cortical gray matter volume in schizophrenia. Am J Psychiatry 1994; 151:842-848
18. Pfefferbaum A, Lim KO, Rosenbloom M, Zipursky RB: Brain magnetic resonance imaging: approaches for investigating schizophrenia. Schizophr Bull 1990; 16:453-476
19. Degreef G, Ashtari M, Bogerts B, Bilder RM, Jody DN, Alvir JM, Lieberman JA: Volumes of ventricular system subdivisions measured from magnetic resonance images in first-episode schizophrenic patients. Arch Gen Psychiatry 1992; 49: 531-537
20. McAllister CG, van Kammen DP, Rehn TJ, Miller AL, Gurklis J, Kelley ME, Yao J, Peters JL: Increases in CSF levels of interleukin-2 in schizophrenia: effects of recurrence of psychosis and medication status. Am J Psychiatry 1995; 152:1291-1297
21. Ganguli R, Brar JS, Chengappa KR, DeLeo M, Yang ZW, Shurin G, Rabin BS: Mitogen-stimulated interleukin-2 production in never-medicated, first-episode schizophrenic patients: the influence of age at onset and negative symptoms. Arch Gen Psychiatry 1995; 52:668-672
22. Ganguli R, Yang Z, Shurin G, Chengappa KN, Brar JS, Gubbi AV, Rabin BS: Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness. Psychiatry Res 1994; 51:1-10
23. Naudin J, Capo C, Giusano B, Mege JL, Azorin JM: A differential role for interleukin-6 and tumor necrosis factor-alpha in schizophrenia? Schizophr Res 1997; 26:227-233
24. Venezie RD, Toews AD, Morell P: Macrophage recruitment in different models of nerve injury: lysozyme as a marker for active phagocytosis. J Neurosci Res 1995; 40:99-107
25. Lotan M, Schwartz M: Cross talk between the immune system and the nervous system in response to injury: implications for regeneration. FASEB J 1994; 8:1026-1033
26. Troost D, Claessen N, van den Oord JJ, Swaab DF, de Jong JM: Neuronophagia in the motor cortex in amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol 1993; 19:390-397
27. Oehmichen M: Cerebrospinal Fluid Cytology. Stuttgart, Germany, G Thieme, 1976
28. Cook JD, Brooks BR: Lymphocyte subpopulations in human cerebrospinal fluid, in Neurobiology of Cerebrospinal Fluid. Edited by Wood JH. New York, Plenum, 1980, pp 507-523
29. Taskinen E: Cerebrospinal Fluid Cells and Proteins in Neurologic Diseases With Known or Suspected Immunoactivation of the Central Nervous System (thesis). Helsinki, University of Helsinki, Transplantation Laboratory and Department of Neurology, 1983
30. Müller K: Involvement of the Nervous System in the Immunobiology of Myasthenia Gravis (thesis). Helsinki, University of Helsinki, Departments of Neurology and Pathology and Transplantation Laboratory, 1990
31. Koelmel HW: Atlas of Cerebrospinal Fluid Cells, 2nd ed. New York, Springer-Verlag, 1977
32. Müller KMI, Elovaara I, Haltia M: Cerebrospinal fluid cytology in early HIV-1 infection, in An Atlas of the Neuropathology of HIV Infection. Edited by Gray F. New York, Oxford University Press, 1993, pp 239-243
33. Vallada HP, Kunugi H: An overview of schizophrenia genetic research presented at the 1995 World Congress on Psychiatric Genetics, Cardiff. Schizophr Res 1996; 19:87-92
34. Kendler KS, MacLean CJ, O'Neill FA, Burke J, Murphy B, Duke F, Shinkwin R, Easter SM, Webb BT, Zhang J, Walsh D, Straub RE: Evidence for a schizophrenia vulnerability locus on chromosome 8p in the Irish Study of High-Density Schizophrenia Families. Am J Psychiatry 1996; 153:1534-1540
35. Turecki G, Rouleau GA, Joober R, Mari J, Morgan K: Schizophrenia and chromosome 6p. Am J Med Genet 1997; 74:195-198
36. Dawson E, Murray R: A gene at 6p? schizophrenia. Curr Biol 1996; 6:268-271
37. Yolken RH, Torrey EF: Viruses as etiologic agents of schizophrenia, in Advances in Biological Psychiatry, vol 18. Edited by Ebert D, Ebmeier WP, Kaschka WP, Rechlin T. Basel, Switzerland, Karger, 1997, pp 1-12
38. Zamani MG, De Hert M, Spaepen M, Hermans M, Marynen P, Cassiman JJ, Peuskens J: Study of the possible association of HLA class II, CD4, and CD3 polymorphisms with schizophrenia. Am J Med Genet 1994; 54:372-377
39. Blackwood DH, Muir WJ, Stephenson A, Wentzel J, Ad'hiah A, Walker MJ, Papiha SS, St Clair DM, Roberts DF: Reduced expression of HLA-B35 in schizophrenia. Psychiatr Genet 1996; 6:51-59
40. Wright P, Donaldson PT, Underhill JA, Choudhuri K, Doherty DG, Murray RM: Genetic association of the HLA DRB1 gene locus on chromosome 6p21.3 with schizophrenia. Am J Psychiatry 1996; 153:1530-1533
41. DeLisi LE, Sakuma M, Tew W, Kushner M, Hoff AL, Grimson R: Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia. Psychiatry Res 1997; 74:129-140
42. Thomas WE: Brain macrophages: evaluation of microglia and their functions. Brain Res Brain Res Rev 1992; 17:61-74
43. De Groot CJ, Huppes W, Sminia T, Kraal G, Dijkstra CD: Determination of the origin and nature of brain macrophages and microglial cells in mouse central nervous system, using non-radioactive in situ hybridization and immunoperoxidase techniques. Glia 1992; 6:301-309
44. Kettenmann H, Banati R, Walz W: Electrophysiological behavior of microglia. Glia 1993; 7:93-101
45. Streit WJ, Graeber MB, Kreutzberg GW: Functional plasticity of microglia: a review. Glia 1988; 1:301-307
46. Peress NS, Fleit HB, Perillo E, Kuljis R, Pezzullo C: Identification of Fc gamma RI, II and III on normal human brain ramified microglia and on microglia in senile plaques in Alzheimer's disease. J Neuroimmunol 1993; 48:71-79
47. Gehrmann J, Banati RB, Kreutzberg GW: Microglia in the immune surveillance of the brain: human microglia constitutively express HLA-DR molecules. J Neuroimmunol 1993; 48:189-198
48. Graeber MB, Streit WJ: Microglia: immune network in the CNS. Brain Pathol 1990; 1:2-5
49. Andersson PB, Perry VH, Gordon S: The kinetics and morphological characteristics of the macrophage-microglial response to kainic acid-induced neuronal degeneration. Neuroscience 1991; 42:201-214
50. Ulvestad E, Williams K, Bjerkvig R, Tiekotter K, Antel J, Matre R: Human microglial cells have phenotypic and functional characteristics in common with both macrophages and dendritic antigen-presenting cells. J Leukoc Biol 1994; 56:732-740
51. Chabot S, Williams G, Yong VW: Microglial production of TNF-alpha is induced by activated T-lymphocytes: involvement of VLA-4 and inhibition by interferonbeta-1B. J Clin Invest 1997; 100:604-612
52. McGillis JP, Mitsuhashi M, Payan DG: Immunomodulation by tachykinin neuropeptides. Ann NY Acad Sci 1990; 594:85-94
53. Martin FC, Anton PA, Gornbein JA, Shanahan F, Merrill JE: Production of interleukin-1 by microglia in response to substance P: role for a non-classical NK-1 receptor. J Neuroimmunol 1993; 42:53-60
54. Hagan RM, Kilpatrick GJ, Tyers MB: Interactions between 5-HT3 receptors and cerebral dopamine function: implications for the treatment of schizophrenia and psychoactive substance abuse. Psychopharmacology (Berl) 1993; 112(suppl 1):68-75
55. Young MR, Matthews JP: Serotonin regulation of T-cell subpopulations and of macrophage accessory function. Immunology 1995; 84:148-152
56. Fricchione GL, Bilfinger TV, Stefano GB: The macrophage and neuropsychiatric disorders. Neuropsychiatry Neuropsychol Behav Neurol 1996; 9:16-29